Dynavax hepatitis B vaccine effective but lots inconsistent

Shares of Dynavax Technologies Corp.plummeted 19 percent Wednesday after the Berkeley company company said its hepatitis B virus vaccine bested a current treatment but said lots of the vaccine were inconsistent.